Dr. Eric S. Rothstein, MD

Dr. Rothstein practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.

Dr. Rothstein's NPI, 1215371646, was assigned on April 29, 2013. Dr. Rothstein graduated from JC Edwards School of Medicine, Marshall University in 2013. Dr. Rothstein holds New Hampshire license 17849.

Dr. Rothstein's primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.

Dr. Rothstein's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dr. Rothstein is also affiliated with Cheshire Medical Center. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Rothstein to 3 more hospitals and 1 medical group, each named with a free account. Dr. Rothstein's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rothstein practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Rothstein's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Rothstein is licensed in New Hampshire.

CMS data shows 1,216 Medicare services from Dr. Rothstein across 21 procedure codes in 2024, for 528 Medicare patients. Medicare paid $145,301 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 528 Medicare patients who saw Dr. Rothstein in 2024. The largest group is 75 to 84, with 230 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rothstein's median patient age at 70, with 37% women.

In 2024, Dr. Rothstein wrote 1,654 Medicare Part D claims for 299 patients. 79% of them were for generic drugs. CMS names the drug for 1,522 of them, across 27 drugs with 11 or more claims each, at $321,617 in total drug cost. In 2023, CMS named 873 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Rothstein for performance year 2024, reported through an alternative payment model (APM). Dr. Rothstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 153 procedures of coronary angioplasty and stenting by Dr. Rothstein, more than 99% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Rothstein, published from 2018 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Percutaneous Coronary Intervention. Dr. Rothstein has published most often in J Soc Cardiovasc Angiogr Interv. Dr. Rothstein's most frequent co-authors are Amit Prabhakar Amin, MD, Alexander Iribarne, MD and Jennifer L. Frampton, DO.

CMS Open Payments shows 116 general payments to Dr. Rothstein from 13 drug and device companies from 2019 to 2025. Travel and lodging make up the largest share, 36% of the total. Terumo Medical Corporation paid the most, $7,022. It also lists 1 research payment totaling $89 in 2022.

Dr. Rothstein graduated from JC Edwards School of Medicine, Marshall University in 2013.